We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TXG market cap is 1.15B. The company's latest EPS is USD -1.4932 and P/E is -6.36.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 183.98M | 141.01M | 153.1M | 151.65M | 165.02M |
| Operating Income | -50.29M | -61.5M | -41.74M | -41.49M | -49.84M |
| Net Income | -48.95M | -59.95M | -37.9M | -35.75M | -49.03M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 298.85M | 491.15M | 516.41M | 618.73M | 610.79M |
| Operating Income | -534.14M | -52.25M | -167.94M | -260.43M | -194.56M |
| Net Income | -542.73M | -58.22M | -166M | -255.1M | -182.63M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 965.14M | 922.91M | 929.67M | 937.79M | 918.64M |
| Total Liabilities | 224.1M | 204.08M | 205.61M | 214.99M | 208.5M |
| Total Equity | 741.04M | 718.83M | 724.06M | 722.8M | 710.13M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 929.34M | 1.02B | 1.03B | 965.14M | 918.64M |
| Total Liabilities | 190.27M | 201.26M | 223.24M | 224.1M | 208.5M |
| Total Equity | 739.07M | 817.57M | 805.74M | 741.04M | 710.13M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.2M | -15.73M | -8.23M | 13.41M | 6.66M |
| Investing | 133.49M | 10.63M | 22.58M | 18.96M | -32.63M |
| Financing | 13.67M | 1.64M | 6.24M | 6.4M | 10.91M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -217.9M | -21.37M | -33.61M | -15.2M | 6.66M |
| Investing | -38.39M | -106.73M | -350.89M | 133.49M | -32.63M |
| Financing | 468.91M | 35.3M | 15.82M | 13.67M | 10.91M |
| Market Cap | 1.15B |
| Price to Earnings Ratio | -6.36 |
| Price to Sales Ratio | 1.9 |
| Price to Cash Ratio | 3.37 |
| Price to Book Ratio | 1.63 |
| Dividend Yield | - |
| Shares Outstanding | 122.3M |
| Average Volume (1 week) | 3.22M |
| Average Volume (1 Month) | 3.18M |
| 52 Week Change | -74.61% |
| 52 Week High | 38.49 |
| 52 Week Low | 9.27 |
| Spread (Intraday) | 0.01 (0.11%) |
| Company Name | 10x Genomics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.10xgenomics.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
